Organization and Summary of Significant Accounting Policies - Additional Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Organization And Summary Of Significant Accounting Policies [Line Items]
Entity incorporation state country code	DE
Company formation date	2007-03
Common stock, shares issued (in shares)	58,099,164	48,077,599
Preferred stock, shares issued (in shares)	0	0
Accumulated deficit	$ (486,039)	$ (416,263)
Aggregate potential future gross sale proceeds	$ 9,215	0
Uncertain tax positions percentage	50.00%
Impairment losses	$ 0	0
Cash and cash equivalents	38,800	50,400
Operating lease right-of-use-asset, net	512	1,495
Operating lease liabilities	836	1,624
Operating lease liabilities, less current portion	0	$ 836
Accrued clinical trial cost	5,700
Accumulated deficit
Organization And Summary Of Significant Accounting Policies [Line Items]
Accumulated deficit	(486,000)
Aggregate potential future gross sale proceeds	$ 100,000